Heat Shock Therapy to Improve Mitochondrial Function in Neuropathy (HOTFUN)
Sponsor: University of Kansas Medical Center
Terminated
Difficulties with study recruitment in target population. Subjects who were enrolled completed study activities.
Other terminated trials from University of Kansas Medical Center
- Benign Prostatic Hyperplasia · Jan 2025
- Fetal Macrosomia · Sep 2024
- Benign Prostatic Hyperplasia · Aug 2024
- Prostate Adenocarcinoma · Phase EARLY_PHASE1 · Nov 2023
- Musculoskeletal Cancer · Phase PHASE4 · Aug 2023
See all terminations from University of Kansas Medical Center
Other Neuropathy trials with similar outcome
This NA trial investigates Neuropathy and PreDiabetes and is currently terminated or withdrawn. University of Kansas Medical Center leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Feb 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Feb 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Sep 2022 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Apr 2022 — Sep 2022 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Nov 2021 — Apr 2022 [monthly]
Recruiting NA
First recorded
Jul 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Kansas Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .